speb/financial-data huggingface dataset:
MED.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: 9342000.00
MED.SW cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -14527000.00
MED.SW cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 642000.00
MED.SW income_statement (annual, 2025-12-31) — General And Administrative Expense: 44543000.00
MED.SW balance_sheet (annual, 2025-12-31) — Goodwill: 165397000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Goodwill: 165397000.00
MED.SW balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 241419000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 241419000.00
MED.SW balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 53181000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 53181000.00
MED.SW balance_sheet (annual, 2025-12-31) — Gross PPE: 203516000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Gross PPE: 203516000.00
MED.SW income_statement (annual, 2025-12-31) — Gross Profit: 204330000.00
MED.SW income_statement (annual, 2025-12-31) — Interest Expense: 7477000.00
MED.SW income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 7477000.00
MED.SW income_statement (annual, 2025-12-31) — Interest Income: 1312000.00
MED.SW income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1312000.00
MED.SW cash_flow (annual, 2025-12-31) — Interest Paid Cff: -4445000.00
MED.SW cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1313000.00
MED.SW balance_sheet (annual, 2025-12-31) — Inventory: 98198000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Inventory: 98198000.00
MED.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 406059000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 406059000.00
MED.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: -146262000.00
MED.SW balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1279000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1279000.00
MED.SW balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 0.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 0.00
MED.SW cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 709000.00
MED.SW cash_flow (annual, 2025-12-31) — Issuance Of Debt: 23997000.00
MED.SW balance_sheet (annual, 2025-12-31) — Land And Improvements: 2090000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 2090000.00
MED.SW balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 18768000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 18768000.00
MED.SW balance_sheet (annual, 2025-12-31) — Long Term Debt: 112774000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 112774000.00
MED.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 131542000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 131542000.00
MED.SW cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
MED.SW balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 0.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 0.00
MED.SW balance_sheet (annual, 2025-12-31) — Long Term Provisions: 2744000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 2744000.00
MED.SW balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 72834000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 72834000.00
MED.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
MED.SW income_statement (annual, 2025-12-31) — Minority Interests: -987000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -108846000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 709000.00
MED.SW balance_sheet (annual, 2025-12-31) — Net Debt: 97221000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Net Debt: 97221000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income: 8349000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 8349000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 9335000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 8349000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 8349000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 9336000.00
MED.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 9336000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -6805000.00
MED.SW income_statement (annual, 2025-12-31) — Net Interest Income: -8028000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -59000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 19577000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
MED.SW income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -8028000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 1000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -12000000.00
MED.SW balance_sheet (annual, 2025-12-31) — Net PPE: 94059000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 94059000.00
MED.SW cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -18552000.00
MED.SW cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 19577000.00
MED.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 34453000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 34453000.00
MED.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 27882000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 27882000.00
MED.SW balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13002000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 13002000.00
MED.SW balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12731000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 12731000.00
MED.SW income_statement (annual, 2025-12-31) — Normalized EBITDA: 22616000.00
MED.SW income_statement (annual, 2025-12-31) — Normalized Income: -8514000.00
MED.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: 34817000.00
MED.SW income_statement (annual, 2025-12-31) — Operating Income: 1934000.00
MED.SW income_statement (annual, 2025-12-31) — Operating Revenue: 269257000.00
MED.SW balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12432612.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12432612.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Current Assets: 1000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 11981000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 11981000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 76022000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 76022000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Inventories: 46416000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Inventories: 46416000.00
MED.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1298000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 19501000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 19501000.00
MED.SW income_statement (annual, 2025-12-31) — Other Operating Expenses: 911000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Payable: 15716000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Payable: 15716000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Properties: 63291000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 63291000.00
MED.SW balance_sheet (annual, 2025-12-31) — Other Receivables: 8640000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Other Receivables: 8640000.00
MED.SW income_statement (annual, 2025-12-31) — Other Special Charges: -8600000.00
MED.SW income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.SW balance_sheet (annual, 2025-12-31) — Payables: 35859000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Payables: 35859000.00
MED.SW balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4150000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4150000.00
MED.SW balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3212000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3212000.00
MED.SW income_statement (annual, 2025-12-31) — Pretax Income: 12788000.00
MED.SW balance_sheet (annual, 2025-12-31) — Properties: 0.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
MED.SW cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 2894000.00
MED.SW cash_flow (annual, 2025-12-31) — Purchase Of Business: -108846000.00
MED.SW cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -6805000.00
MED.SW cash_flow (annual, 2025-12-31) — Purchase Of Investment: -59000.00
MED.SW cash_flow (annual, 2025-12-31) — Purchase Of PPE: -18670000.00
MED.SW balance_sheet (annual, 2025-12-31) — Raw Materials: 2334000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2334000.00
MED.SW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 64927000.00
MED.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 25451000.00
MED.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4420000.00
MED.SW income_statement (annual, 2025-12-31) — Research And Development: 31436000.00
MED.SW income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -14500000.00
MED.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: -8182000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -8182000.00
MED.SW cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
MED.SW cash_flow (annual, 2025-12-31) — Sale Of PPE: 118000.00
MED.SW income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 128181000.00
MED.SW income_statement (annual, 2025-12-31) — Selling General And Administration: 172724000.00
MED.SW balance_sheet (annual, 2025-12-31) — Share Issued: 13632277.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Share Issued: 13632277.00
MED.SW cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 23997000.00
MED.SW cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -4420000.00
MED.SW income_statement (annual, 2025-12-31) — Special Income Charges: 23100000.00
MED.SW cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1560000.00
MED.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 275872000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 275872000.00
MED.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 34453000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 34453000.00
MED.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 6237000.00
MED.SW income_statement (annual, 2025-12-31) — Tax Provision: 3453000.00
MED.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.27
MED.SW balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1928000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1928000.00
MED.SW cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -3595000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Assets: 559922000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 559922000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 388646000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 388646000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Debt: 157720000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 157720000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 275872000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 275872000.00
MED.SW income_statement (annual, 2025-12-31) — Total Expenses: 267323000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 284050000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 284050000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 364640000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 364640000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 195877000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 195877000.00
MED.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 26011000.00
MED.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 1863000.00
MED.SW balance_sheet (annual, 2025-12-31) — Total Tax Payable: 4054000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 4054000.00
MED.SW income_statement (annual, 2025-12-31) — Total Unusual Items: 23100000.00
MED.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 23100000.00
MED.SW balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 16357000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 16357000.00
MED.SW balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 1199665.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 1199665.00
MED.SW balance_sheet (annual, 2025-12-31) — Treasury Stock: 240000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 240000.00
MED.SW balance_sheet (annual, 2025-12-31) — Work In Process: 14685000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Work In Process: 14685000.00
MED.SW balance_sheet (annual, 2025-12-31) — Working Capital: 107109000.00
MED.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: 107109000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -6750460000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 5849580000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -693110000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Amortization: 22560000.00
MEDANTA.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 22565000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 253236430.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Basic EPS: 7.75
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 8838160000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 368840000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 825480000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 253650504.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Diluted EPS: 7.73
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 33020000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2495100000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Interest Income: 167220000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 167220000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 4685180000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1039520000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Net Debt: 7184300000.00
MEDANTA.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -5300000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 98440000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 218720000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 510950000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 803980000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Other Investments: 104380000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 1121900000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 512280000.00
MEDANTA.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 91662000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 128530000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Preferred Stock: 0.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 109480000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 500860000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 537560000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 537560000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Research And Development: 590000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 9529600000.00
MEDANTA.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 83678000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 31180000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 73680000.00
MEDANTA.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 238840000.00
MEDANTA.NS income_statement (annual, 2022-03-31) — Write Off: 33358000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 15584560000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 26828040000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1946930000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1942020000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -8175990000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 10670500000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -586860000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Amortization: 25040000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 25040000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 333420000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 259208847.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Basic EPS: 12.58
MEDANTA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1194320000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 11335240000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2359880000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 2797320000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 536390000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 7672430000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 12603940000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 5590440000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 2081990000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -69830000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 201310000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 507650000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 603620000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -214560000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 1028190000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 6478110000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 536390000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 24282080000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 4785480000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3269750000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 6252850000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 15794880000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 342560000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1051020000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1393580000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 5725550000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 129950000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Depreciation: 1474110000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 1499150000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 1499150000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 1474110000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 259460833.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Diluted EPS: 12.57
MEDANTA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — EBIT: 5267540000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — EBITDA: 6766690000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 7672430000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 3456370000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 46830000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 4085310000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 6770000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 3962220000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 51670000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2528880000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 31894950000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Gross Profit: 20575190000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Interest Expense: 774640000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 774640000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Interest Income: 355360000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 355360000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -888110000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 344540000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Inventory: 603710000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 32704280000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3423450000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 333420000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 4785480000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 390750000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 4685190000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 2454760000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 7371180000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 9825940000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 390750000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -666480000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 540420000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1264630000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 4785480000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 749770000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 11920000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 3260790000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 4492900000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 3260790000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -507930000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -231240000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -275730000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -275730000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -507930000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -35290000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1184840000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 23718960000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -2351910000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 24230410000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 237860000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 257080000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 188060000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 540420000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 333450000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 6849650000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Normalized Income: 3320999472.37
MEDANTA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 6445190000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Operating Income: 4990630000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 26828040000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 268195172.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 141328000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 189890000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 51350000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 51670000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 271240000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 10000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 468369000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 137520000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3132730000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 1344690000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 11340140000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 289380000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 4931510000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Other Special Charges: 6770000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Payables: 3291620000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 47390000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 127810000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 178730000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Pretax Income: 4492900000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 65400000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1416079000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -2359880000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 556880000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 6252850000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 1499150000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 633670000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 633670000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -666480000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Research And Development: 340000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 177100000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 12837900000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 7970000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 249070000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 4211290000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 268195172.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Special Income Charges: -82960000.00
MEDANTA.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 7480000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 24282080000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 24230410000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -22750527.63
MEDANTA.NS income_statement (annual, 2023-03-31) — Tax Provision: 1232110000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
MEDANTA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1061440000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 41159650000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 31653260000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 11219520000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 24282080000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Total Expenses: 21837410000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 16877570000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 25364770000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 11152020000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 88650000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -82960000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -82960000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 359740000.00
MEDANTA.NS balance_sheet (annual, 2023-03-31) — Working Capital: 10069330000.00
MEDANTA.NS income_statement (annual, 2023-03-31) — Write Off: 76190000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — +Operating Expense: 18233200000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — +Total Revenue: 32409420000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1867780000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2153130000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -8976400000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 10679010000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -659010000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Amortization: 25020000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 25020000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 103910000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 268607382.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Basic EPS: 17.80
MEDANTA.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 7672430000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 11565150000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2785850000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 3825320000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 537010000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 4246080000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 11561250000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 3105300000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1140780000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -64790000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -85790000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 85610000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Payable: 17690000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -484060000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -459110000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -3426350000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Common Stock: 537010000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 29056270000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 70000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 3862790000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 7593600000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Assets: 15087300000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 360160000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1358710000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1718870000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 6177330000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 189030000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Depreciation: 1702260000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 1727280000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 1727280000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 1702260000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 268607382.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Diluted EPS: 17.80
MEDANTA.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 4781940000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — EBIT: 6996380000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — EBITDA: 8723660000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — End Cash Position: 4246080000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -5139240000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 47450000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 3334990000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -8200000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 4958550000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 55430000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 2812140000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 35155430000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Gross Profit: 24815820000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Interest Expense: 725390000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 725390000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Interest Income: 596780000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 596780000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -325040000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 589200000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Inventory: 668500000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 33249640000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -4407950000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 103910000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 70000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1363240000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 5198650000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 3465160000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 2834660000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 6299820000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1363240000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -5822120000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 577410000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1406930000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -340000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Minority Interests: 1340000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 70000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 16690000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income: 4781940000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 4781940000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 4780600000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 4781940000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 4781940000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 6270990000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 4780600000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: 0.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Interest Income: -241030000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 172570000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -4458880000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -4458880000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -241030000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -113310000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -2398140000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Net PPE: 26179030000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2771580000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 29000840000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 289100000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 613240000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 241580000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 577410000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 284550000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 8916720000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Normalized Income: 4929116544.05
MEDANTA.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 6120840000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Operating Income: 6582620000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Operating Revenue: 32409420000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 268507382.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 168640000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 28640000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 43850000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 55430000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -5940000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 173120000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 480000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 141660000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 3611450000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1489680000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Properties: 13121910000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 302060000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 7315170000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Other Special Charges: -8200000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Payables: 3357460000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 72230000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 175740000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 210780000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Pretax Income: 6270990000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 59080000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: 0.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2785850000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 668500000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7593600000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 1727280000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 636760000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 636760000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -5822120000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Research And Development: 420000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 191580000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 17643790000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 172570000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 14270000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 291850000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 5250400000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Share Issued: 268507382.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Special Income Charges: -193060000.00
MEDANTA.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 1560000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 29056270000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 29000840000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -45883455.95
MEDANTA.NS income_statement (annual, 2024-03-31) — Tax Provision: 1490390000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.24
MEDANTA.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1774640000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Assets: 43040750000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 31890930000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Debt: 8018690000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 29055930000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Total Expenses: 25826800000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 13984820000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 27953450000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 7807490000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 112420000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -193060000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -193060000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 397000000.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
MEDANTA.NS balance_sheet (annual, 2024-03-31) — Working Capital: 8909970000.00
MEDANTA.NS income_statement (annual, 2024-03-31) — Write Off: 201260000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2070550000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2830090000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 518160000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 3865980000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 537090000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 2997670000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 10186550000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 537090000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 31414860000.00
MEDANTA.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 4528780000.00